من الأشهر اليوم؟

A new cancer vaccine has shown a 100 percent success rate when treating aggressive melanoma in mice. Researchers at Scripps Research Institute in La Jolla, Calif. and the University of Texas in Dallas, gave mice suffering from melanoma a cancer immunotherapy drug called anti-PD-L1, which prevents tumor cells from attacking their immune systems. The study...